1. Home
  2. RCKT vs SYBT Comparison

RCKT vs SYBT Comparison

Compare RCKT & SYBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • SYBT
  • Stock Information
  • Founded
  • RCKT 1999
  • SYBT 1904
  • Country
  • RCKT United States
  • SYBT United States
  • Employees
  • RCKT N/A
  • SYBT N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • SYBT Major Banks
  • Sector
  • RCKT Health Care
  • SYBT Finance
  • Exchange
  • RCKT Nasdaq
  • SYBT Nasdaq
  • Market Cap
  • RCKT 328.6M
  • SYBT 2.3B
  • IPO Year
  • RCKT N/A
  • SYBT N/A
  • Fundamental
  • Price
  • RCKT $3.25
  • SYBT $74.81
  • Analyst Decision
  • RCKT Buy
  • SYBT Hold
  • Analyst Count
  • RCKT 13
  • SYBT 3
  • Target Price
  • RCKT $12.96
  • SYBT $83.67
  • AVG Volume (30 Days)
  • RCKT 5.7M
  • SYBT 86.5K
  • Earning Date
  • RCKT 11-06-2025
  • SYBT 10-22-2025
  • Dividend Yield
  • RCKT N/A
  • SYBT 1.63%
  • EPS Growth
  • RCKT N/A
  • SYBT 22.18
  • EPS
  • RCKT N/A
  • SYBT 4.35
  • Revenue
  • RCKT N/A
  • SYBT $364,546,000.00
  • Revenue This Year
  • RCKT N/A
  • SYBT $16.83
  • Revenue Next Year
  • RCKT $108.43
  • SYBT $5.12
  • P/E Ratio
  • RCKT N/A
  • SYBT $17.45
  • Revenue Growth
  • RCKT N/A
  • SYBT 11.32
  • 52 Week Low
  • RCKT $2.19
  • SYBT $57.12
  • 52 Week High
  • RCKT $22.01
  • SYBT $83.83
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 51.65
  • SYBT 50.67
  • Support Level
  • RCKT N/A
  • SYBT N/A
  • Resistance Level
  • RCKT $3.30
  • SYBT $77.82
  • Average True Range (ATR)
  • RCKT 0.16
  • SYBT 1.60
  • MACD
  • RCKT -0.13
  • SYBT -3.40
  • Stochastic Oscillator
  • RCKT 86.92
  • SYBT 89.24

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About SYBT Stock Yards Bancorp Inc.

Stock Yards Bancorp Inc operates as a bank. The bank has two reportable operating segments namely Commercial Banking and Wealth Management and Trust. Its services include loan and deposit services, cash management services, securities brokerage activities, mortgage origination, and others. It generates the majority of its revenue from the Commercial Banking segment.

Share on Social Networks: